Trial intelligence / Profile preview

Gabapentin vs placebo for pain after central venous catheter insertion

IRCT20120215009014N535Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial comparing Gabapentin with Placebo (2 arms). Primary endpoint: Post-procedural pain intensity. Started Nov 2024; status: completed.

02

Drugs

gabapentin

Beyond the preview

Go deeper on IRCT20120215009014N535.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N535.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call